Nashville BiosciencesNashville Biosciences
  • Home
  • About
    • Meet the Team
    • Join the Team
    • Press
  • Our Work
    • Disease Cohorts
    • Product Offerings
    • Case Studies
      • Synthetic Control Arm to Boost Clinical Development
      • Measuring the Impact of New Drug Treatments
      • Improving Early-Stage Drug Discovery Process
      • Early Stage Drug Target Prioritization
      • Disease Risk Modeling
      • Pharmacovigilance
  • Contact
    • Partner with Us
  • Home
  • About
    • Meet the Team
    • Join the Team
    • Press
  • Our Work
    • Disease Cohorts
    • Product Offerings
    • Case Studies
      • Synthetic Control Arm to Boost Clinical Development
      • Measuring the Impact of New Drug Treatments
      • Improving Early-Stage Drug Discovery Process
      • Early Stage Drug Target Prioritization
      • Disease Risk Modeling
      • Pharmacovigilance
  • Contact
    • Partner with Us

Ownage

http://themenectar.com/demo/salient/video/big_buck_bunny.mp4
  • 0 Shares Share
    0
  • 1

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Proin eu diam lorem, id scelerisque sapien. In accumsan metus at magna vehicula placerat tempor varius ipsum.

  • Branding
  • HTML/CSS
  • Illustration
  • Macro Lens
  • Photography
A site-wide Call to Action Section! Have you fallen in love yet? Buy This Theme!

3841 Green Hills Village Dr., Suite 200
Nashville, TN 37215-2691

4660 La Jolla Village Drive
Suites 100 & 200
San Diego, California 92122

(615)-208-5462
info@nashvillebiosciences.com

LinkedIn
Twitter

Privacy Policy

© Nashville Biosciences, LLC. All Rights Reserved.

Leveraging Vanderbilt University Innovation™

WHO WE ARE

Our History

Genomics is one of the fastest developing research areas in the world today. Due to rapid advancements, in-depth genetic analysis has become essential in R&D and clinical practice.

With drug development costs forecast to double every nine years, we need more than ever to improve R&D productivity and uncover new ways to diagnose and care for diseases more efficiently. In order to increase the speed-to-market for life sciences companies, it’s imperative that we fully recognize and capture the potential of human genetics in drug and diagnostics R&D.

Button Text